Sutimlimab is the first inhibitor of complement protein component 1,s subcomponent (C1s) for the study of cold agglutinin syndrome, a serine protease that cleaves C4 and C2 to form C3 convertase.
Purity:
98.0%
CAS Number:
[2049079-64-1]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted
